IL162594A0 - Process and intermediates for pyridazinone antidiabetic agents - Google Patents

Process and intermediates for pyridazinone antidiabetic agents

Info

Publication number
IL162594A0
IL162594A0 IL16259403A IL16259403A IL162594A0 IL 162594 A0 IL162594 A0 IL 162594A0 IL 16259403 A IL16259403 A IL 16259403A IL 16259403 A IL16259403 A IL 16259403A IL 162594 A0 IL162594 A0 IL 162594A0
Authority
IL
Israel
Prior art keywords
pyridazinone
intermediates
antidiabetic agents
antidiabetic
agents
Prior art date
Application number
IL16259403A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL162594A0 publication Critical patent/IL162594A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16259403A 2002-01-09 2003-01-03 Process and intermediates for pyridazinone antidiabetic agents IL162594A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34767902P 2002-01-09 2002-01-09
PCT/IB2003/000013 WO2003057691A1 (en) 2002-01-09 2003-01-03 Process and intermediates for pyridazinone antidiabetic agents

Publications (1)

Publication Number Publication Date
IL162594A0 true IL162594A0 (en) 2005-11-20

Family

ID=23364775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16259403A IL162594A0 (en) 2002-01-09 2003-01-03 Process and intermediates for pyridazinone antidiabetic agents

Country Status (22)

Country Link
US (1) US6759534B2 (de)
EP (1) EP1463725B1 (de)
JP (1) JP2005514421A (de)
KR (1) KR100604502B1 (de)
CN (1) CN1269814C (de)
AR (1) AR038267A1 (de)
AT (1) ATE302201T1 (de)
AU (1) AU2003200847A1 (de)
BR (1) BR0306730A (de)
CA (1) CA2472331A1 (de)
DE (1) DE60301324T2 (de)
DK (1) DK1463725T3 (de)
ES (1) ES2246464T3 (de)
HU (1) HUP0500031A2 (de)
IL (1) IL162594A0 (de)
MX (1) MXPA04005646A (de)
PL (1) PL371258A1 (de)
PT (1) PT1463725E (de)
RU (1) RU2278116C2 (de)
TW (1) TWI250980B (de)
WO (1) WO2003057691A1 (de)
ZA (1) ZA200404798B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途
CN105732552B (zh) * 2016-04-12 2017-12-01 天津师范大学 2位或3‑位硫代苯并呋喃化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328770A1 (de) * 1983-08-10 1985-02-28 Basf Ag, 6700 Ludwigshafen Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.

Also Published As

Publication number Publication date
ZA200404798B (en) 2006-02-22
CN1615307A (zh) 2005-05-11
WO2003057691A1 (en) 2003-07-17
ATE302201T1 (de) 2005-09-15
RU2004121026A (ru) 2006-01-10
MXPA04005646A (es) 2004-12-06
KR100604502B1 (ko) 2006-07-25
DE60301324D1 (de) 2005-09-22
DK1463725T3 (da) 2005-11-21
EP1463725B1 (de) 2005-08-17
PL371258A1 (en) 2005-06-13
US6759534B2 (en) 2004-07-06
BR0306730A (pt) 2004-12-21
RU2278116C2 (ru) 2006-06-20
TW200302098A (en) 2003-08-01
DE60301324T2 (de) 2006-05-24
PT1463725E (pt) 2005-10-31
EP1463725A1 (de) 2004-10-06
TWI250980B (en) 2006-03-11
AU2003200847A1 (en) 2003-07-24
US20030162969A1 (en) 2003-08-28
HUP0500031A2 (hu) 2005-04-28
CN1269814C (zh) 2006-08-16
HK1072598A1 (en) 2005-09-02
AR038267A1 (es) 2005-01-12
ES2246464T3 (es) 2006-02-16
CA2472331A1 (en) 2003-07-17
JP2005514421A (ja) 2005-05-19
KR20040072710A (ko) 2004-08-18

Similar Documents

Publication Publication Date Title
AU2003206028A1 (en) Antidiabetic agents
GB0115517D0 (en) Novel antidiabetic agents
AU2003219942A8 (en) Composition and process for well cleaning
EP1550657A4 (de) Aminverbindungen und deren verwendung
AU2003253188A8 (en) Novel processes and intermediates for preparing triazolo-pyridines
PL369569A1 (en) Oral antidiabetic agents
GB0222909D0 (en) Novel process and intermediates
GB0221513D0 (en) Novel compounds and processes
AP2147A (en) A composition for treating aids and associated conditions.
GB0123961D0 (en) Process and intermediates
GB0222912D0 (en) Novel process and intermediates
GB0220385D0 (en) Compound and process
PL371258A1 (en) Process and intermediates for pyridazinone antidiabetic agents
PL371539A1 (en) Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
GB0202187D0 (en) "Inhibitors"
AU2003215804A1 (en) Antidiabetic agents
SI1463725T1 (sl) Postopek in intermediati za piridazinonska antidiabeticna sredstva
AUPS337802A0 (en) Method of screening for antidiabetic agents
GB0021315D0 (en) Heterocyclic compounds and intermediates thereof
GB0113298D0 (en) Purification process and intermediates
AU2003213281A8 (en) Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
IL166087A0 (en) Process for preparing nateglinide and intermediates thereof
GB0215867D0 (en) Novel method and compounds
GB0206657D0 (en) Novel intermediate and process
HUP0402141A3 (en) Herbicidal composition and process for its use